Cargando…

A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA

OBJECTIVE: Breast invasive carcinoma (BRCA), as a systemic disease, is currently the most malignant tumor among women. Early detection of BRCA will increase the probability of cure. Pyrimidine metabolism (PyM) stands for an essential metabolic pathway related to DNA replication of cancer cells, whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaoxue, Zhang, Qiang, Xie, Xianxin, Li, Yang, Pang, Zhiyuan, Yu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866008/ https://www.ncbi.nlm.nih.gov/pubmed/35224098 http://dx.doi.org/10.1155/2022/7201963

Ejemplares similares

Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature
por: Luo, Yongzhou, et al.
Publicado: (2022)

A pyrimidine scheme to restore mRNA export
por: Short, Ben
Publicado: (2012)

Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer
por: Yamagata, M, et al.
Publicado: (1999)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer
por: Li, Xueping, et al.
Publicado: (2020)

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA‐negative breast cancers
por: Xu, Ye, et al.
Publicado: (2017)

Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)

A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017)

An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis
por: Xiong, Jie, et al.
Publicado: (2014)

A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2018)

Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells
por: Lattimore, Vanessa L., et al.
Publicado: (2019)

Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis
por: Chen, Xueran, et al.
Publicado: (2019)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

Five-mRNA Signature for the Prognosis of Breast Cancer Based on the ceRNA Network
por: Shi, Wenjie, et al.
Publicado: (2020)

The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
por: Meng, Zibo, et al.
Publicado: (2020)

An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer
por: Xiong, Yongfu, et al.
Publicado: (2017)

Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines
por: Fustier, P, et al.
Publicado: (2003)

A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients
por: Wu, Bo, et al.
Publicado: (2021)

A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients
por: Wang, Fangce, et al.
Publicado: (2018)

Identification of a 13-mRNA signature for predicting disease progression and prognosis in patients with bladder cancer
por: Yin, Hubin, et al.
Publicado: (2020)

Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer
por: Kim, Hee Sung, et al.
Publicado: (2019)

Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export
por: Zhang, Liang, et al.
Publicado: (2012)

Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma
por: Shi, Yu, et al.
Publicado: (2018)

Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma
por: Zhong, Lin-Kun, et al.
Publicado: (2020)

A Starvation-Based 9-mRNA Signature Correlates With Prognosis in Patients With Hepatocellular Carcinoma
por: Lei, Dengliang, et al.
Publicado: (2021)

A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma
por: Zhou, Yang, et al.
Publicado: (2022)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2
por: Gu, Yunyan, et al.
Publicado: (2014)

Characterization of BRCA1/2-Directed ceRNA Network Identifies a Novel Three-lncRNA Signature to Predict Prognosis and Chemo-Response in Ovarian Cancer Patients With Wild-Type BRCA1/2
por: Zhang, Meiling, et al.
Publicado: (2020)

Bioinformatics analysis of esophageal cancer unveils an integrated mRNA-lncRNA signature for predicting prognosis
por: Lan, Tian, et al.
Publicado: (2020)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA
por: Zhu, Jun-Yu, et al.
Publicado: (2022)

Prognostic and predictive value of a mRNA signature in peripheral T‐cell lymphomas: A mRNA expression analysis
por: Tu, Jiannan, et al.
Publicado: (2020)

Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
por: Yeh, Hsi-Wen, et al.
Publicado: (2017)

A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer
por: Zhang, Chen, et al.
Publicado: (2020)

Development of a circHIPK3-based ceRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation
por: Lian, Qi-xin, et al.
Publicado: (2023)

Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis
por: Wu, Zhengxin, et al.
Publicado: (2021)

Quantitative Analysis of BRCA1 and BRCA2 mRNA Expression in Sporadic Breast Carcinomas and Its Relationship with Clinicopathological Characteristics
por: Egawa, Chiyomi, et al.
Publicado: (2001)

Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations
por: Wangensteen, Teresia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m25cra8uoasdnhfk24oaljc73s